Vascepa is a prescription medication that contains the active ingredient icosapent ethyl and is used to reduce the risk of cardiovascular events in certain adult patient groups. According to the FDA, Vascepa is approved for use in adults with elevated triglyceride levels who are at high risk of cardiovascular events, such as heart attacks and strokes [2]. The FDA approval does not mention any specific age group, so it can be assumed that the medication is available for all age groups of adults who meet the criteria for its use.

As for the availability of discounts, the website Drug Patent Watch provides information on the patent status of Vascepa, but it does not mention anything about discounts for the medication [1]. It is important to note that discounts for prescription medications are typically offered by the manufacturer or through insurance plans, so it would be best to check with the manufacturer or the patient's insurance provider to determine if any discounts are available for Vascepa.

In summary, Vascepa is approved for use in certain adult patient groups, but there is no indication that it is restricted by age. However, the availability of discounts for the medication would need to be confirmed with the manufacturer or the patient's insurance provider.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.fda.gov/news-events/press-announcements/fda-approves-use-drug-reduce-risk-cardiovascular-events-certain-adult-patient-groups
[3] https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202057s035lbl.pdf